These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8778838)

  • 21. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine.
    Ohmori T; Abekawa T; Muraki A; Koyama T
    Pharmacol Biochem Behav; 1994 Jul; 48(3):587-91. PubMed ID: 7938110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial learning deficit after NMDA receptor blockade and state-dependency.
    Kretschmer BD; Fink S
    Behav Pharmacol; 1999 Jul; 10(4):423-8. PubMed ID: 10780810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The non-competitive NMDA antagonist MK-801 increases food intake in rats.
    Burns GA; Ritter RC
    Pharmacol Biochem Behav; 1997 Jan; 56(1):145-9. PubMed ID: 8981622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
    Muraki A
    Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced locomotor stimulation by NMDA receptor antagonists in alcohol-sensitive ANT rats.
    Vekovischeva OY; Haapalinna A; Näkki R; Sarviharju M; Honkanen A; Heikkilä J; Korpi ER
    Pharmacol Biochem Behav; 2000 Dec; 67(4):793-9. PubMed ID: 11166070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
    De Leonibus E; Mele A; Oliverio A; Pert A
    Neuroscience; 2001; 104(1):105-16. PubMed ID: 11311535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists.
    Tomitaka S; Hashimoto K; Narita N; Minabe Y; Tamura A
    Eur J Pharmacol; 1995 Oct; 285(2):207-11. PubMed ID: 8566141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Wedzony K
    J Neural Transm (Vienna); 1996; 103(1-2):131-46. PubMed ID: 9026367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.
    Chartoff EH; Heusner CL; Palmiter RD
    Neuropsychopharmacology; 2005 Jul; 30(7):1324-33. PubMed ID: 15688082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuating effect of serotonin receptor antagonists on impairment of mealtime-associated activity rhythm in old rats.
    Shibata S; Ono M; Minamoto Y; Watanabe S
    Pharmacol Biochem Behav; 1995; 51(2-3):541-4. PubMed ID: 7667383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effect of NMDA receptor antagonist MK-801 on nocturnal serotonin N-acetyltransferase activity in the rat pineal gland.
    Zawilska JB; Rosiak J; Senderecka M; Nowak JZ
    Pol J Pharmacol; 1997; 49(6):479-83. PubMed ID: 9566052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairments of movement initiation and execution induced by a blockade of dopamine D1 or D2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors.
    Hauber W
    Neuroscience; 1996 Jul; 73(1):121-30. PubMed ID: 8783236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical effects of very low dose MK-801.
    Tang Y; Zou H; Strong JA; Cui Y; Xie Q; Zhao G; Jin M; Yu L
    Eur J Pharmacol; 2006 May; 537(1-3):77-84. PubMed ID: 16626696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.
    Leriche L; Schwartz JC; Sokoloff P
    Neuropharmacology; 2003 Aug; 45(2):174-81. PubMed ID: 12842123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
    Gnegy ME; Hewlett GH; Pimputkar G
    Brain Res; 1996 Sep; 734(1-2):35-42. PubMed ID: 8896805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the N-methyl-d-aspartate receptor antagonist on locomotor activity and cholecystokinin-induced anorexigenic action in a goldfish model.
    Kang KS; Yahashi S; Matsuda K
    Neurosci Lett; 2011 Jan; 488(3):238-41. PubMed ID: 21094216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.